C4 Therapeutics, Inc. CCCC
Regular-session close
After hours · Nov 20, 4:22 PM ET
- YTD
- +29.84%
- 1 year
- +4.20%
CCCC free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-99,301,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -99,301,000 | -33,964,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -65,337,000 | 43,209,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -108,546,000 | 2,889,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -111,435,000 | -23,193,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -88,242,000 | -20,343,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -67,899,000 | -122,227,000 | -224.98% |
| FY 2019 | 2019-12-31 | 54,328,000 | 73,998,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -19,670,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:43.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
